Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Eye prosthesis – Intraocular lens
Patent
1997-03-12
1999-08-31
Prebilic, Paul B.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Eye prosthesis
Intraocular lens
623 5, 427 224, 427 21, A61F 216
Patent
active
059447532
ABSTRACT:
A minus power anterior chamber ocular implant for placement in the anterior chamber of a phakic eye having an anatomic lens in situ comprises a negative artificial refracting lens having at least one concave surface, a surface coating which comprises a compatible sulfated polysaccharide medicament coating, such as heparin, and having a structure which positions the artificial lens in the anterior chamber of the eye to prevent contact between the implant and the anatomic lens. The implant compensates for refractive errors or creates a specific refraction to assist in visual function and has increased biocompatibility in the anterior chamber of the eye, thereby preventing or mitigating detrimental effects typically associated with the implantation of an uncoated refractive anterior chamber implant in the eye. A method of preparing such a minus power anterior chamber ocular implant comprises first exposing an uncoated implant to a plasma to generate a plasma-treated implant having a surface containing amines, carboxylic acids, active free radicals or passive free radicals, and thereafter bonding the medicament to the plasma-treated implant surface. A method of treating myopia comprises surgically implanting and anchoring the implant in the phakic eye to compensate for refractive errors.
REFERENCES:
patent: 598861 (1898-03-01), Delano
patent: 839084 (1906-12-01), Fleming
patent: 3766167 (1973-10-01), Lasker et al.
patent: 4170043 (1979-10-01), Knight et al.
patent: 4174543 (1979-11-01), Kelman
patent: 4240163 (1980-12-01), Galin
patent: 4249271 (1981-02-01), Poler
patent: 4343050 (1982-08-01), Kelman
patent: 4437194 (1984-03-01), Hahs
patent: 4448718 (1984-05-01), Yannas et al.
patent: 4478981 (1984-10-01), Arkles
patent: 4502162 (1985-03-01), Gerhard et al.
patent: 4504981 (1985-03-01), Walman
patent: 4613517 (1986-09-01), Williams et al.
patent: 4676792 (1987-06-01), Praeger
patent: 4681585 (1987-07-01), Sanyo et al.
patent: 4687484 (1987-08-01), Kaplan
patent: 4713244 (1987-12-01), Bawa et al.
patent: 4716154 (1987-12-01), Malson et al.
patent: 4731080 (1988-03-01), Galin
patent: 4816032 (1989-03-01), Hetland
patent: 4826478 (1989-05-01), Schocket
patent: 4840626 (1989-06-01), Linsky et al.
patent: 4871363 (1989-10-01), Kelman
patent: 4955901 (1990-09-01), Nishiguchi et al.
patent: 5071432 (1991-12-01), Baikoff
patent: 5080924 (1992-01-01), Kamel et al.
patent: 5258025 (1993-11-01), Fedorov et al.
patent: 5652014 (1997-07-01), Galin et al.
"Cell loss prompts redesign of ACL for phakic myopia".
"The Eye" by G. Wstheimer, in Medical Physiology, Thirteenth edition, edited by V.B. Mountcastle, vol. 1, pp. 440-442.
Brochure of Kabi Pharmacia (Uppala Sweden).
"Surface-Modified IOL's: A new approach to cataract surgery", publisher by Pharmacia AB (Uppala, Sweden).
Piera Versura B.S.D. et al. "Ultrastructure of cells centered onto various intraocular lens materials" J. Cataract Refract Surg., vol. 18 pp. 58-64.
Piera Versura, B.S.D. et al., "Ultrastructure of cells cultured onto various intraocular lens materials" J. Cataract Refract Surg., vol. 18, pp. 58-64.
Bjorn Lundgren, Ph.D., "Inflammatory response in the rabbit eye after intraocular implantation with poly(methyl methacrylate) and heparin surface modified intraocular lenses" J. Cataract Refract. Surg., vol. 18, pp. 65-70, (1992).
Bo Philipson M.D., "Heparin surface modified intraocular lenses Three-month follow-up of a randomized, doublemasked clinical trial", J. Cataract Refract. Surg., vol. 18, pp. 71-78, (1992).
Lawrence M. Fisher, "An Implant That Corrects the Cornea's Curvature", Tech. Notes N.Y. Times Business Section, May (1991).
"Minus Power Anterior Chamber Lenses for High Myopia" in Ophtamology alert, vol. 1, No. 11, pp. 41-42 (Nov. 1990).
"Heparin-modified Surface Looks Promising in IOL Clinical Trials" in Opthamology Times, Nov. 1, p. 54 (1990).
Joseph Colin, M.D. et al., The Surgical Treatment of High Myopia: Comparison of Epikeratoplasty Keratomileusis and Minus Power Anterior Chamber Lenses, Refractive & Corneal Surgery, vol. 6, pp. 245-260, (1990).
Prof. Baikoff, "Domilens The Future", European Leader in Biotechnology Adapt to Ophtahmology, May, (1990).
R. Larsson et al. "Intraocular PMMA Lenses Modified With Surfact-immobilized Heparin: Evaluation of Biocompatiblity in vitro and in vivo." Biomaterials 10:511-516 (1989).
R. Larsson et al. "The Search for Thromboresistance Using Immobilized Heparin" Ann. N.Y. Acad. Sci. 516: 102-115 (1987).
Kaufman et al., "Corneal Endothelium Damage with Intraocular Lenses: Contact Adhesion Between Surgical materials and Tissue"vol. 198 Science pp. 525-527, Nov. 4, 1977.
Katz et al., "Prevention of Endothelial Damage From Intraocular Lens Insertion" vol. 83 Trans. American Academy of Ophthalmol. Otolaryngol, pp. Op-204 to op-212, Oct. 7, 1976.
VMG Ferguson et al. "Continued breakdown of the blood aqueous barrier follow cataract surgery", British Journal of Opthamology, vol. 76, pp. 453-456 (1992).
Abstracts of WO 9007914, DE 2128527 and DE 2725219.
Galin Miles A.
Israel Stanley C.
Salamone Joseph C.
LandOfFree
Medicament coated refractive anterior chamber ocular implant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament coated refractive anterior chamber ocular implant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament coated refractive anterior chamber ocular implant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2425170